Trial Type: Multiple Myeloma

BH-P-DREAMM-10
A Phase 3, randomized, open-label study of belantamab mafodotin administered in combination with lenalidomide and dexamethasone (BRd) versus daratumumab, lenalidomide, and dexamethasone (DRd) in participants with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation
Protocol Status: OPEN TO ACCRUAL
Trial Type: Multiple Myeloma
Contact: Niroula, Rabin
rabin.niroula@BrownHealth.org
LS-P-MAGNETISMM-32
A Phase 3, Open-Label Study Of Elranatamab Monotherapy Versus Elotuzumab, Pomalidomide, Dexamethasone (Epd) Or Pomalidomide, Bortezomib, Dexamethasone (Pvd) Or Carfilzomib, Dexamethasone (Kd) In Participants With Relapsed/ Refractory Multiple Myeloma Who Received Prior Anti-Cd38 Directed Therapy
Protocol Status: OPEN TO ACCRUAL
Trial Type: Multiple Myeloma
Contact: Niroula, Rabin
rabin.niroula@BrownHealth.org
HEM/ONC-TISSUE/FLUID-BANK
Hematology/Oncology Tissue/Body Fluid Banking for Research Purposes
Protocol Status: OPEN TO ACCRUAL
Trial Type: Leukemia, Lymphoma, Multiple Myeloma
Contact: Reagan, John
jreagan@BrownHealth.org
LS-P-MAST
LS-P-MAST: A Phase 1/2, Open Label, First-In-Human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Tumor Activity of SAR445877 Administered as Monotherapy in Adults with Advanced Solid Tumors
Protocol Status: OPEN TO ACCRUAL
Trial Type: Breast, Endocrine Neuroendocrine, Eye, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal, Other Hematology, Skin, Thoracic, Unknown Primary
Contact: Almhanna, Khaldoun
kalmhanna@BrownHealth.org
19-027-LCI-BLPR
19-027: LCI-BLPR: Lifespan Cancer Institute Disposable/Replaceable Biospecimen Labelling Protocol and Patient Registry: A Pilot Study
Protocol Status: OPEN TO ACCRUAL
Trial Type: Breast, Endocrine Neuroendocrine, Eye, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal, Neurologic, Other Hematology, Skin, Thoracic, Unknown Primary
Contact: Azzoli, Christopher
cazzoli@BrownHealth.org
LS-P-COE-001-0815
LS-P-COE-001-0815: Caris Molecular Intelligence® and Caris Centers of Excellence for Precision Medicine Network Outcomes Associated Repository
Protocol Status: OPEN TO ACCRUAL
Trial Type: Breast, Endocrine Neuroendocrine, Eye, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal, Neurologic, Other Hematology, Skin, Thoracic, Unknown Primary
Contact: El-Deiry, Wafik
Wafik.El-Deiry@BrownHealth.org
TCRB
TCRB: Clinical Protocol for the Translational Cancer Research Biorepository
Protocol Status: OPEN TO ACCRUAL
Trial Type: Breast, Endocrine Neuroendocrine, Eye, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal, Neurologic, Other Hematology, Skin, Thoracic, Unknown Primary
Contact: Yakirevich, Evgeny
EYakirevich@BrownHealth.org